In this Applied Clinical Trials video interview, Marie Teil, Global Head of UCB’s Women of Childbearing Age Program, talks about the role of technology in addressing the data gap in women's health research and encourages women interested in healthcare to go for it.
Innovative digital technologies without doubt going to play a crucial role in in bridging this gap that we just talked about, I think I see it in two ways, first in terms of healthcare monitoring, but also in terms of data generation, interpretation, dissemination. So, technology is already enabling women to actively monitor their daily health indicators and participate in their health care management. For example, managing medications and tracking physical activities. Period ovulation trackers are another great example of at home monitoring for women. But beyond monitoring technologies should improve both the systematic generation and the interpretation of gender data throughout our research and development process. And I think by harnessing the power of AI, we can potentially shift to a more precise approach to drug design and discovery, which can also lead to more personalized medicine. So, there are exciting opportunities with AI and machine learning algorithm to analyze large data set, I notify pattern related to women's health.
This technology could help uncover perhaps hidden insights from existing data and help generate hypotheses for future research. So, this will ultimately enable women to contribute data for research and engage with a health metrics most significantly, leading to better health outcomes. And finally, something we need to think about is, we need more textured technological innovation to enable sharing data and information between the patients and their physicians to facilitate the discussion and their reproductive journey, in particular, related to their disease, but to the health in general as well.
I would say go for it. We need more women interested in healthcare, in pharmaceuticals, and in technology technologies, who are passionate, and really wish to contribute to advancing science and impacting women's health. Whether it's for family planning, disease management, or for society, in general, actually, I would say it's still a very challenging field. But it's extremely rewarding, because we see the direct impact of what we do for current, but also for future generations. And I think for us women, it's really, really important to see that there's a huge potential for future careers. I would love to see more enthusiastic young women in this area of work, really. I would say I encourage you to follow me on LinkedIn for more on what I'm working on, or you can also visit UCB.com
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.